DVAX
Dynavax Technologies Corporation Healthcare - Drug Manufacturers - Specialty & Generic Investor Relations →
Dynavax Technologies Corporation (DVAX) closed at $15.50 as of 2026-02-02, trading 29.1% above its 200-week moving average of $12.01. The stock is currently moving closer to the line, down from 29.3% last week. With a 14-week RSI of 89, DVAX is in overbought territory.
Over the past 1098 weeks of data, DVAX has crossed below its 200-week moving average 24 times. On average, these episodes lasted 29 weeks. The average one-year return after crossing below was -11.2%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $1820 million, DVAX is a small-cap stock. The company generates a free cash flow yield of 2.8%. Return on equity stands at -7.1%. The stock trades at 3.4x book value.
Over the past 21.2 years, a hypothetical investment of $100 in DVAX would have grown to $22, compared to $862 for the S&P 500. DVAX has returned -7.0% annualized vs 10.7% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -43.1% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: DVAX vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After DVAX Crosses Below the Line?
Across 24 historical episodes, buying DVAX when it crossed below its 200-week moving average produced an average return of -7.6% after 12 months (median -12.0%), compared to +11.3% for the S&P 500 over the same periods. 30% of those episodes were profitable after one year. After 24 months, the average return was -30.4% vs +20.4% for the index.
Each line shows $100 invested at the moment DVAX crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
DVAX has crossed below its 200-week MA 24 times with an average 1-year return of +-11.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Feb 2005 | Aug 2005 | 26 | 44.9% | -3.2% | -75.4% |
| Oct 2005 | Oct 2005 | 3 | 4.9% | +25.5% | -74.5% |
| Nov 2005 | Feb 2006 | 13 | 32.6% | +15.5% | -68.9% |
| Feb 2006 | Feb 2006 | 1 | 0.0% | -7.6% | -73.9% |
| Apr 2006 | Oct 2006 | 26 | 33.7% | -8.0% | -73.5% |
| Feb 2007 | Feb 2008 | 55 | 35.9% | -10.7% | -73.6% |
| Mar 2008 | Dec 2010 | 143 | 96.5% | -67.5% | -26.9% |
| Aug 2011 | Aug 2011 | 1 | 1.0% | +77.3% | -25.1% |
| Sep 2011 | Oct 2011 | 3 | 8.1% | +153.4% | -19.7% |
| Nov 2012 | Nov 2012 | 1 | 0.7% | -44.7% | -36.5% |
| Feb 2013 | Jul 2015 | 123 | 59.6% | -6.1% | -21.7% |
| Oct 2015 | Nov 2015 | 6 | 7.2% | -54.7% | -35.0% |
| Jan 2016 | Jan 2016 | 1 | 11.2% | -79.3% | -26.4% |
| Feb 2016 | Jul 2017 | 78 | 77.7% | -81.0% | -26.4% |
| Jan 2018 | Jan 2018 | 2 | 4.1% | -29.8% | -1.6% |
| Mar 2018 | Mar 2018 | 1 | 0.0% | -51.5% | -5.5% |
| Apr 2018 | May 2018 | 1 | 0.7% | -57.6% | -5.5% |
| May 2018 | Feb 2021 | 141 | 79.4% | -70.2% | -4.3% |
| Feb 2021 | Mar 2021 | 3 | 15.9% | +42.6% | +77.1% |
| Mar 2021 | Apr 2021 | 1 | 1.4% | +15.7% | +59.3% |
| Apr 2021 | Aug 2021 | 15 | 22.0% | -0.7% | +61.6% |
| Apr 2024 | May 2024 | 4 | 5.0% | -3.5% | +38.3% |
| Jun 2024 | Nov 2024 | 19 | 12.5% | -11.8% | +38.0% |
| Apr 2025 | Dec 2025 | 37 | 24.9% | N/A | +37.8% |
| Average | 29 | — | +-11.2% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02